In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug-drug interactions.
Masamrekh RA, Kuzikov AV, Haurychenka YI, Shcherbakov KA, Veselovsky AV, Filimonov DA, Dmitriev AV, Zavialova MG, Gilep AA, Shkel TV, Strushkevich NV, Usanov SA, Archakov AI, Shumyantseva VV.
Masamrekh RA, et al.
Fundam Clin Pharmacol. 2020 Feb;34(1):120-130. doi: 10.1111/fcp.12497. Epub 2019 Aug 5.
Fundam Clin Pharmacol. 2020.
PMID: 31286572